The Scientist - Home

A new machine learning model promises fast prediction of drug-target interactions.

Tumors overexpress certain genes to survive a growing pile of harmful mutations, a trait that scientists could exploit to target with drugs.

Algorithms can now glean ever more molecular and genetic information from images of stained tissue, but some researchers worry that we can’t follow their logic.

Steven Barker is on a forty-seven-year-long journey to understand the mind-blowing science of psychedelics.

According to Erin Schuman, science driven by fascination rather than tools will guide new discoveries.

Khalid Shah engineers stem cells to deliver cancer therapeutics directly to tumors, thereby increasing their efficacy.

By studying the genomes of more than 24,000 individuals, researchers discovered rare genetic mutations that may shed light on mechanisms underlying schizophrenia.

A new, invisible fluorescent patch continuously monitors blood glucose levels in mice.

Researchers investigated how cancer antigenicity drives unique forms of T cell exhaustion and hypofunctionality.

Biogerontologist Matt Kaeberlein studies aging pets to determine how to improve healthspan in dogs and their humans.

By delivering mRNA to the skin of mice in utero, researchers showed a proof-of-concept for shuttling gene therapies to skin cells before birth.

Oncolytic viruses can help glioblastoma respond to immunotherapy.